Københavns Universitet
19 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 6 name spellings.
3
Ending by 2030
May 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 6, 2026The maintenance fee for Inhaler with acoustic flow monitoring (US 11,666,714) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
- 1 fee due Jan 30, 2027The maintenance fee for Azatriangulenium salts as PET-quenched fluorescent probes (US 10,364,249) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 22, 2026
- Oct 13 US 12,758,528 Compounds Having Pseudomonas Anti-Biofilm Properties
- Sep 22 US 12,742,006 GLP1R Agonist Nmdar Antagonist Conjugates
- 1 term has ended since Aug 22, 2026
- Oct 16 US 10,100,290 Glycosyltransferase Glycosylating Flavokermesic Acid And/Or or Kermesic Acid · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,318,084 | Method and device for cleaning air In force · USPTO record | In force | USPTO record | |
| US 8,546,321 | IL-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases In force · USPTO record | In force | USPTO record | |
| US 8,633,007 | Diagnosis of endometritis In force · USPTO record | In force | USPTO record | |
| US 8,846,891 | Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1) In force · USPTO record | In force | USPTO record | |
| US 9,491,958 | Process for the Manufacture of a Product from a Plant Material In force · High confidence | In force | High confidence | |
| US 10,292,406 | Process for the Manufacture of a Product from a Plant Material In force · High confidence | In force | High confidence | |
| US 9,572,365 | Bovine colostrum as minimal enteral nutrition for preterm infants In force · USPTO record | In force | USPTO record | |
| US 10,233,328 | Sol-Gel Based Matrix In force · High confidence | In force | High confidence | |
| US 11,236,233 | Sol-gel based matrix In force · USPTO record | In force | USPTO record | |
| US 10,364,249 | Azatriangulenium salts as PET-quenched fluorescent probes In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 25: 19 patents in force now held by others · 17 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
9 pending · 6 abandoned · 23 no status recorded